Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 55,014,384
  • Shares Outstanding, K 1,417,166
  • Annual Sales, $ 9,913 M
  • Annual Income, $ -82,000 K
  • 60-Month Beta 0.87
  • Price/Sales 5.54
  • Price/Cash Flow 18.10
  • Price/Book 3.60
Trade BSX with:

Options Overview

Details
  • Implied Volatility 37.82%
  • Historical Volatility 24.50%
  • IV Percentile 72%
  • IV Rank 15.71%
  • IV High 99.69% on 03/16/20
  • IV Low 26.29% on 02/05/21
  • Put/Call Vol Ratio 0.76
  • Today's Volume 749
  • Volume Avg (30-Day) 6,925
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 79,542
  • Open Int (30-Day) 97,664

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.30
  • Number of Estimates 12
  • High Estimate 0.32
  • Low Estimate 0.29
  • Prior Year 0.28
  • Growth Rate Est. (year over year) +7.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
36.88 +2.85%
on 02/18/21
39.96 -5.07%
on 02/25/21
-0.83 (-2.14%)
since 02/04/21
3-Month
33.42 +13.49%
on 12/14/20
39.96 -5.07%
on 02/25/21
+3.52 (+10.23%)
since 12/04/20
52-Week
24.10 +57.39%
on 03/23/20
42.37 -10.48%
on 09/03/20
-0.82 (-2.12%)
since 03/04/20

Most Recent Stories

More News
Heart Valve Devices Market Industry Demand, Top Players, Industry Future Growth By 2025

Selbyville, Delaware, Market Study Report has added a detailed report on Heart Valve Devices Market which has been categorized by market size, growth indicators and encompasses detailed market analysis...

ABT : 116.01 (-2.66%)
BSX : 37.93 (-2.29%)
LIFE : 4.44 (+2.78%)
LIVN : 79.60 (+1.40%)
NVCN.TO : 1.45 (-10.49%)
Boston Scientific (BSX) Buys Lumenis to Expand in Urology

The transaction is expected to remain immaterial to Boston Scientific's (BSX) 2021 adjusted earnings per share.

OMI : 30.34 (-4.86%)
VIVO : 21.07 (+0.19%)
BSX : 37.93 (-2.29%)
NVST : 37.86 (-2.07%)
Baring Private Equity Asia Announces Agreement to Sell Lumenis' Surgical Business to Boston Scientific for USD1.07 billion

YOKNEAM, and , /PRNewswire/ -- Baring Private Equity Asia (BPEA) and announced today that they have entered into a definitive agreement to sell the Lumenis Surgical Business to Boston Scientific (NYSE:...

BSX : 37.93 (-2.29%)
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now

Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.

MDT : 115.27 (-2.27%)
HOLX : 70.41 (-2.17%)
BSX : 37.93 (-2.29%)
IDXX : 485.85 (-2.44%)
Boston Scientific Announces Agreement To Acquire Lumenis LTD. Surgical Business From Baring Private Equity Asia

, /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business...

BSX : 37.93 (-2.29%)
SERB completes acquisition of BTG Specialty Pharmaceuticals to create a global leader in critical care medicines

, /PRNewswire/ -- SERB Specialty Pharmaceuticals ("SERB"), a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life-threatening diseases, today announced...

BSX : 37.93 (-2.29%)
Transcatheter devices market is expected to grow at a CAGR of around 12% during the forecast period 2019 to 2026

pune, India, Fri, 26 Feb 2021 01:35:23 / Comserve Inc. / -- Acumen Research and Consulting, Recently Published Report on titled "Transcatheter Devices Market Size, Share, Growth Opportunities and Forecast,...

BSX : 37.93 (-2.29%)
CRY : 24.55 (-3.42%)
EW : 81.88 (-2.81%)
NVCN.TO : 1.45 (-10.49%)
Heart Valve Devices Market 2025 Overall View of Opportunities, Challenges, Key Players, Growth Rate

Selbyville, Delaware Market Study Report Has Added A New Report On Heart Valve Devices Market That Provides A Comprehensive Review Of This Industry With Respect To The Driving Forces Influencing The Market...

ABT : 116.01 (-2.66%)
BSX : 37.93 (-2.29%)
LIFE : 4.44 (+2.78%)
LIVN : 79.60 (+1.40%)
NVCN.TO : 1.45 (-10.49%)
Cardiovascular Devices Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Cardiovascular Devices Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027747/?utm_source=GNW

ABT : 116.01 (-2.66%)
BSX : 37.93 (-2.29%)
CAH : 52.20 (-1.97%)
MDT : 115.27 (-2.27%)
Hemorrhoid Treatment Devices Market Valuation to Cross USD 973.94 Million by 2025 at Substantial CAGR of 5.98%, Predicts Market Research Future (MRFR)

Hemorrhoid Treatment Devices Market Overview:

BSX : 37.93 (-2.29%)
CNMD : 118.45 (-3.43%)
MDT : 115.27 (-2.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

3rd Resistance Point 40.38
2nd Resistance Point 39.73
1st Resistance Point 38.83
Last Price 37.93
1st Support Level 37.28
2nd Support Level 36.63
3rd Support Level 35.73

See More

52-Week High 42.37
Last Price 37.93
Fibonacci 61.8% 35.39
Fibonacci 50% 33.24
Fibonacci 38.2% 31.08
52-Week Low 24.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar